Home » Newsletters » BioWorld

BioWorld

Feb. 21, 2001

View Archived Issues

U.S. Patent Disclosures

Medarex Partners With Immusol To Develop Antibody Therapies

Other News To Note

Correction

Gilead Plans Regulatory Filings Based On Pivotal Tenofovir Trial

Panel Urges Wider Perspective On Market's 'Random Movement'

Xenova, Cantab Agree To Merge UK Companies Targeting Cancer

Alkermes, Janssen Plan NDA On Sustained-Release Risperdal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026